| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
23.04.2025 15:55:11
|
EQS-News: Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies
|
EQS-News: Benzinga
/ Key word(s): Healthcare
By Meg Flippin Benzinga DETROIT, MICHIGAN - April 23, 2025 (NEWMEDIAWIRE) - Lance Alstodt, CEO of BioRestorative Therapies (NASDAQ: BRTX), was recently a guest on Benzinga’s All-Access.  BioRestorative Therapies is a regenerative medicine company that wants to alleviate chronic lower back pain, obesity and diabetes and is developing stem cell therapies to meet that end. The company’s flagship program, BRTX-100, which is in a phase 2 clinical trial, uses a patient’s stem cells to alleviate chronic back pain. Meanwhile, ThermoStem® uses adipose-derived (brown fat) stem cells to generate new brown fat tissue to target metabolic diseases, including obesity and type 2 diabetes. Both are addressing unmet health needs that inflict pain and suffering on millions of people around the world. Watch the full interview here: Featured image by Joyce Hankins on Unsplash. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. This content was originally published on Benzinga. Read further disclosures here. News Source: Benzinga
23.04.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Benzinga |
| United States | |
| ISIN: | US0906556065 |
| EQS News ID: | 2122726 |
| End of News | EQS News Service |
|
|
2122726 23.04.2025 CET/CEST
Nachrichten zu BioRestorative Therapies Inc Registered Shs
Analysen zu BioRestorative Therapies Inc Registered Shs
3 Knaller-Aktien im BX Musterportfolio📈: Dollarama, Telekom & Waste Connections mit François Bloch
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ Dollarama
✅ Telekom
✅ Waste Connections
Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Aktien in diesem Artikel
| BioRestorative Therapies Inc Registered Shs | 1.36 | -9.33% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Verhaltene Stimmung: SMI kaum bewegt -- DAX fester -- Japanischer Leitindex Nikkei 225 freundlichDer heimische Aktienmarkt zeigt sich im Montagshandel kaum verändert, während der deutsche Aktienmarkt zulegen kann. Die wichtigsten asiatischen Indizes zeigen sich zum Wochenstart mehrheitlich etwas fester.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |